2004

Sep 28, 2004
Guidant Reports Positive Six-Month Results from the SPIRIT FIRST Everolimus Eluting Coronary Stent Trial

Results Demonstrate the Benefit of An Everolimus Eluting Coronary Stent with Durable Polymer; Investor Briefing Scheduled for 8:00 a.m. ET Tomorrow Indianapolis, Ind., and Washington, D.C. -...

Sep 28, 2004
Guidant Applauds Decision That Will Expand Defibrillator Coverage to Thousands More Medicare Beneficiaries

Lifesaving Benefits of Implantable Defibrillators Supported by Multiple Clinical Trials Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today applauds the proposed...

Sep 27, 2004
Guidant Announces Plans to Initiate Groundbreaking Vulnerable Plaque Study

Goal of Study Is To Help Physicians Recognize Patients At Risk of Unexpected Heart Attack Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced plans to conduct...

Sep 16, 2004
Guidant Receives FDA Approval for Small Vessel Cobalt Chromium Coronary Stent

Highly Deliverable New Stent Broadens Guidant''s Market-Leading Metallic Stent Portfolio Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and...

Sep 14, 2004
Guidant Announces Enrollment Completion for Largest Clinical Trial to Study Right Ventricular Pacing

International Trial Will Study Unnecessary Pacing in Heart Failure Patients Indianapolis, Ind. And St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that it has completed...

Show 5102550100 per page
Top